title: Cytostatic drugs in the treatment of severe vasculitides. Indications, results and risks.
abstract: The indications for cytostatic drugs in the treatment of cerebral vasculitis are discussed as well as the possible risks of long-term immunosuppressive therapy.
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D013700:Giant Cell Arteritis / Q000188:drug therapy; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D014657:Vasculitis / Q000188:drug therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone